CIENCIASMEDICASNEWS

jueves, 22 de octubre de 2026

Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature Communications

https://www.news-medical.net/news/20261022/Modus-Therapeutics-SEVUSMART-study-of-sevuparin-in-children-with-severe-malaria-published-in-Nature-Communications.aspx Modus Therapeutics Holding AB (publ) announces that the manuscript based on the Phase Ib study SEVUSMART in severe malaria, lead-authored by Professor Kathryn Maitland of Imperial College London with co-authors from the SMAART consortium including members such as University College London and the University of Oxford, has been published today in the peer-reviewed journal Nature Communications, following independent peer review. The manuscript was submitted in June 2026 and made available ahead of peer review as a preprint via Research Square.

Artificial intelligence in stroke rehabilitation: A structured clinical review

https://www.news-medical.net/news/20261022/Artificial-intelligence-in-stroke-rehabilitation-A-structured-clinical-review.aspx Stroke is a major cause of long-term disability, and recovery varies substantially across motor, cognitive, communication, and activities-of-daily-living domains, making continuous assessment and individualized rehabilitation essential. However, current rehabilitation decisions still rely heavily on periodic clinical scales, clinician experience, and local resources, which may not fully capture differences in lesion characteristics, baseline function, comorbidities, and recovery trajectories. Access is also limited by geographic barriers, uneven service capacity, and intermittent follow-up.

Can GLP-1 Drugs Help Treat Osteoarthritis and Relieve Joint Pain?

https://www.news-medical.net/health/Can-GLP-1-Drugs-Help-Treat-Osteoarthritis-and-Relieve-Joint-Pain.aspx Researchers are investigating how appetite- and blood-glucose-regulating drugs interact with cartilage, inflammation, and osteoarthritis biology. Osteoarthritis (OA) is the most common joint disorder and a leading cause of pain and disability worldwide. This condition is characterized by progressive degeneration of articular cartilage, accompanied by changes in subchondral bone, synovium, and other joint tissues.

How GLP-1 Drugs Affect Cancer Risk: Evidence, Mechanisms, and Safety

https://www.news-medical.net/health/How-GLP-1-Drugs-Affect-Cancer-Risk-Evidence-Mechanisms-and-Safety.aspx Can metabolic treatments change cancer risk? Studies of GLP-1 receptor agonists examine how weight loss, insulin regulation, and tumor biology may intersect. Since their approval, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have improved management of metabolic conditions such as obesity and type 2 diabetes (T2D). Given the well-established association between weight loss and reduced cancer risk, researchers are investigating whether these drugs could also protect against cancer.

What Is Inflammaging? Causes, Health Effects, and Ways to Reduce Inflammation

https://www.news-medical.net/health/What-Is-Inflammaging-Causes-Health-Effects-and-Ways-to-Reduce-Inflammation.aspx As the body ages, subtle changes in immune function can fuel persistent inflammation. Scientists are uncovering the cellular processes behind this phenomenon and investigating whether diet, exercise, and emerging therapies could change its course. Acute inflammation is a protective immune response to injury or infection that normally resolves after the trigger is cleared and tissue repair proceeds. Chronic inflammation can develop when inflammatory triggers persist, or the mechanisms that regulate and resolve inflammation become impaired.1

Are shared fryers really off-limits for people with celiac disease?

https://www.news-medical.net/news/20261022/Are-shared-fryers-really-off-limits-for-people-with-celiac-disease.aspx French fries and tortilla chips cooked alongside gluten-containing foods may not always pose the risk previously assumed, as new research finds that most samples contained low gluten levels, with fryer oil changes emerging as a potentially important factor. People with celiac disease are commonly advised to avoid foods prepared in fryers also used for gluten-containing foods. However, a recent study published in Nutrients found that most French fries and tortilla chips prepared in shared fryers contained gluten levels below the US regulatory threshold for gluten-free labeling, suggesting that contamination risk may be lower than commonly assumed in some food-service settings.